Skip to content

Relationship of MTHFR gene and schizophrenia

Identification of variants of methylene-tetrahydro-folate-reductase(MTHFR) gene in schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027329
Enrollment
100
Registered
2020-08-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G- Mental Health

Interventions

Intervention1: risperidone: started at dose of 2mg, incremented with intent to treat analysis for 6 weeks Control Intervention1: risperidone and vitamin B12 plus folic acid supplements: vitamin B12 an

Sponsors

Government Medical College and Hospital Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed with schizophrenia as per ICD 11 2) Age of the patients shall be between 18-45 years. 3) Patients not on any psychotropics for past 2 weeks. 4) Patients willing to participate and give consent or in case the patient lacks mental capacity, his/her nominated representative willing to give consent to participate. 5) Patients not having a major diet change that is shifting of non vegetarian diet to vegetarian diet or vice versa in past 3 months.

Exclusion criteria

Exclusion criteria: 1) Patients who are not willing to give consent. 2) Pregnant and breast feeding patients. 3) Patients with co-morbid psychiatric illness and substance dependence. 4) Patients with severe medical and surgical illness. 5) Patients with history of depot antipsychotic administration in the past 3 months. 6) Patient already on vitamin b12 and folic acid supplements.

Design outcomes

Primary

MeasureTime frame
to compare the improvement in psychopathology in patients with first episode schizophrenia receiving risperidone alone and risperidone plus vitamin B12 and folic acid supplements at 6 weeks respectivelyTimepoint: baseline, 2 weeks,4 weeks, 6 weeks

Secondary

MeasureTime frame
To compare the improvement in psychopathology in patients with first episode Schizophrenia receiving Risperidone alone and Risperidone plus Vitamin B12 and Folic acid supplements at 6 weeks respectivelyTimepoint: 6 weeks

Countries

India

Contacts

Public ContactDR BS CHAVAN

government medical college and hospital, sector 32, chandigarh

drchavanbs@gmail.com9646121611

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026